Halozyme Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $138.8M | $181.8M | $43.3M |
| FY2016 | $294.0M | $261.5M | $66.8M |
| FY2017 | $311.6M | $519.9M | $168.7M |
| FY2018 | $191.4M | $440.2M | $57.9M |
| FY2019 | $474.1M | $565.9M | $120.2M |
| FY2020 | $428.9M | $579.9M | $147.7M |
| FY2021 | $907.5M | $1.10B | $118.7M |
| FY2022 | $1.67B | $1.84B | $234.2M |
| FY2023 | $1.65B | $1.73B | $118.4M |
| FY2024 | $1.70B | $2.06B | $115.9M |